Showing 48 results

Report on elimination of this disease from Mallorca

ZSL listing work with Imperial on mapping Bd

Alkion BioInnovations and its awards

Information for Phase III Clinical Trials

Study which highlighted that Bd had been introduced into Mallorca

List of more than 70 granted patent identified via searching in Google Patents with “Phyre AND Protein”

Cooperation agreement between Brasilia Ambiental and Banco do Brasil Foundation

Term of Reference published by the Department for Conservation of Ecosystems within the Brazilian Ministry of Environment

Phase 2 trials results

Bsal and Bd idenitifed as a threat to local wildlife from exotic species.

Evonik press release on strategic importance of Alkion BioPharma to its business

Story confirming Thomson Environmental Consultants and Imperial College London's partnership

Wildlife diseases on the increase: a serious threat for Europe's biodiversity
A BiodivERsA policy brief based on the RACE project results

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial

Neoplanta withania brochure from Evonik

Funding for a second trial

Research paper for Apple of Sodom, shows the directly link between Ahava and Evonik's use of Alkion Biopharma

COMMISSION IMPLEMENTING DECISION (EU) 2018/320
of 28 February 2018
on certain animal health protection measures for intra-Union trade in salamanders and the
introduction into the Union of such animals in relation to the fungus Batrachochytrium
salamandrivorans

News story relating to Imperial's work with the Somerset Otter Group.

Results from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study